• Upgrades Also Include Integration with Apple Health, Manual Post-Workout Logging

PLEASANTON, Calif., March 10, 2025 /PRNewswire/ -- Movano Health (Nasdaq: MOVE), a pioneer in health technology and maker of the Evie Ring, today announced a series of new data personalization, trend tracking and integration features on the ring's companion app that expand support for women's wellness journeys. The enhancements follow January's beta release of EvieAI, the first wearable-based virtual wellness assistant built exclusively with training data from medical journals.

Available immediately on the iOS version of the Evie app, the new features include:

• Integration with Apple Health – Evie data can now be automatically imported into Apple Health, enabling users to view information from both platforms in one location.
• New 7- and 30-day trend graphs – The app now displays multi-day graphs showing trends for all sleep metrics captured by Evie's medical-grade sensors – including respiration rate average, resting heart rate, heart rate variability and skin temperature variability plus blood oxygen saturation (Sp02) – as well as for the mood and energy levels that users record in the app's log. These graphs help consumers better understand their patterns over time.
• Daily basal body temperature logging – Users can now log their BBT daily as part of their journal activity, aiding their cycle tracking efforts.
• Heart rate mapping – The app now provides a graph showing users' heart rate throughout the day with color-coding indicating hours spent active, inactive and asleep, plus a list of total hours spent in each state, for easy tracking of daily movement.
• Expansion of workout tracking – In addition to logging workouts as they happen, Evie has added the ability to manually add a past workout. This makes it possible to receive credit for calories burned and active minutes even if the user hasn't worn the ring during exercise.
• Cycle day and phase added to Daily Summary home screen – Evie's unique at-a-glance Daily Summary of activities and recovery now also includes the user's menstrual cycle day and phase. This adds to the one-stop value of the home screen, which dynamically displays the user's activity, steps, calories, sleep and mood in a single graphic that makes it easy to see progress toward pre-set goals.

"Every new feature we add is designed to help women navigate their wellness journey, whether through more personalization, easier trend analysis, or correlations across multiple metrics to provide insights that can help users optimize their daily routines," said Movano Chief Marketing Officer Tyla Bucher. "These latest upgrades represent the most requested enhancements from the Evie community, and we have many others in the pipeline that will continue to enrich the Evie experience."

The Evie Ring costs $269 with no subscription fees, keeping costs low over the life of the wearable, and is eligible for HSA/FSA fund reimbursement. It is compatible with both Apple and Android devices, and is available exclusively at www.eviering.com in gold, rose gold and silver finishes and in sizes 5-12 with an optional complimentary sizing kit for those who don't know their ring size.

About Movano Health 

Founded in 2018, Movano Inc. (Nasdaq: MOVE) dba Movano Health is developing a suite of purpose-driven healthcare solutions to bring medical-grade data to the forefront of wearables. Featuring modern and flexible form factors, Movano Health's Evie and EvieMED devices offer an innovative approach to delivering trusted data to both customers and enterprises, capturing a comprehensive picture of an individual's health data and uniquely translating it into personalized and intelligent insights. Movano Health's proprietary technologies and wearable medical device solutions enable the use of data as a tool to proactively monitor and manage health outcomes. For more information visit https://movanohealth.com/.

Forward Looking Statements

This press release contains forward-looking statements concerning our expectations, anticipations, intentions, beliefs, or strategies regarding the future. These forward-looking statements are based on assumptions that we have made as of the date hereof and are subject to known and unknown risks and uncertainties that could cause actual results, conditions, and events to differ materially from those anticipated. Therefore, you should not place undue reliance on forward-looking statements. Examples of forward-looking statements include, among others, statements we make regarding plans with respect to the commercial launches of the Evie Ring and EvieMED; our expectations regarding potential commercial opportunities and addressable markets; planned cost-cutting initiatives; anticipated FDA clearance decisions with respect to our products; expected future operating results; product development efforts and product releases; clinical trial and regulatory initiatives; commercial partner activities; our strategies, positioning and expectations for future events or performance. Important factors that could cause actual results to differ materially from those in the forward-looking statements are set forth in our most recent Annual Report on Form 10-K and any subsequent Quarterly Reports on Form 10-Q, and in our other reports filed with the Securities and Exchange Commission, including under the caption "Risk Factors."  Any forward-looking statement in this release speaks only as of the date of this release. We undertake no obligation to publicly update any forward-looking statement, whether written or oral, that may be made from time to time, whether as a result of new information, future developments or otherwise.